Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Gynecologic 2CNS 2Breast 2Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 4Rectal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Salivary Gland Neoplasms 1Liver Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Hepatocellular 1Cachexia 1

Interventions

Carboplatin 3Filgrastim 2tislelizumab 1sargramostim 1milademetan 1etoposide phosphate 1aldesleukin 1Topotecan 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Microarray Analysis 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Ifosfamide 1Etoposide 1Dasatinib 1Cyclophosphamide 1Blotting, Western 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × Immunologic Techniques × Gastrointestinal × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡